Vipul Jairath, MBChB, DPhil, FRCP, FRCPC, is a consultant to Alimentiv. He oversees the medical R&D initiatives and services. In conjunction with the executive team and senior medical advisors, he assumes overall responsibility for research strategy.
Dr. Jairath obtained his BSc (pharmacology) and medical degree from the University of Leeds (U.K.), DPhil (Ph.D.) in clinical medicine from the University of Oxford, and post-graduate diploma in clinical trials from the London School of Hygiene and Tropical Medicine. He is Professor of Medicine at the Schulich School of Medicine and Dentistry, and holder of the John W.D and Susan McDonald Endowed Chair in Inflammatory Bowel Disease (IBD) at Western University.
He is a practicing gastroenterologist and specialist in inflammatory bowel disease, and his research interests in clinical therapeutics for IBD include design of clinical trials, development and validation of outcome measures for use in clinical trials, patient reported outcome measures, and prediction modeling for response to therapy.
Achievements
Vipul has driven the development and validation of several novel indices for use in IBD clinical trials, like the UC-100 and the novel patient reported outcome measures, SIQ-UC and SIQ-CD. In addition, he was instrumental to the delivery of the REACT-2 trial, he is the global PI for the VERDICT and VECTORS trials, both of which are important clinical practice questions for patients with Crohn’s disease and ulcerative colitis, respectively.
